Global Antimicrobial Susceptibility Test Market to Reach USD 3814.0 Million by 2025

The global antimicrobial susceptibility test market has a highly competitive vendor landscape. Some of the companies dominating the global antimicrobial susceptibility test market are Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Dickinson and Company, and Creative Diagnostics. These players are trying to expand product offerings and business expansion for widening customer base. The global antimicrobial susceptibility test market pegged the value of USD 2578.4 million in the year 2016 and is expected to attain a value of USD 3814.0 million by the end of the year 2025. The market is anticipated to swell with a CAGR of 4.6 percent from 2017 to 2025. Based on the test type, the antibacterial segment dominated the global antimicrobial susceptibility test market owing to the increasing number of bacterial infections. On the basis of region, North America dominated the global pet wearable market followed by Europe in the year 2016. Both the regions collectively accounted for the share of 66.3 percent in the pet wearable market. However, Asia Pacific is expected to expand with a CAGR of 5.4 percent from 2017 to 2025.

Growing awareness about health to propel growth

Antimicrobial susceptibility tests have wide applications for determining specific antibiotic for the treatment of bacterial or fungal infection. A growing number of patients, suffering from bacterial or fungal infection is leading to boost adoption of antimicrobial susceptibility tests, which in turn is propelling the growth of the global antimicrobial susceptibility test market. Additionally, the Centers for Disease Control and Prevention (CDC) expects that antibacterial resistance caused to increase the number of infected people to 2 million and near about 23,000 deaths in the US. Effective treatments and diagnostic tests are required for detecting these infections. Thus, the demand for the newer broadband for the antibacterial drug is rising. This is a key factor in boosting the growth of the antimicrobial susceptibility test market. Growing awareness about health and infection control in healthcare systems coupled with growing disposable income and growing expenditure on health is boosting the adoption of antimicrobial susceptibility tests. This factor is another important factor in boosting the growth of the global antimicrobial susceptibility test market.

Growing infection and bacterial diseases to propel growth

Despite these growth opportunities, the factors such as inappropriate diagnosis, patent expirations, low patient compliance, stringent regulatory procedures, and lack of firm return on investment are likely to hamper the growth of the global antimicrobial susceptibility test market. Nonetheless, widening application of tests to detect which bacteria are affected is witnessing higher adoption for clinical purposes. Additionally, growing diseases such as E. coli, Salmonella, and Enterococcus are expected to offer lucrative opportunities for growth of the global antimicrobial susceptibility test market. – Transparency Market Research